1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The tumor promoter cysteinyl leukotriene receptor 1 regulates PD-L1 expression in colon cancer cells via the Wnt/β-catenin signaling axis
(
- Contribution to journal › Article
- 2022
-
Mark
Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers
(
- Contribution to journal › Article
- 2021
-
Mark
Brain-derived neurotrophic factor, neutrophils and cysteinyl leukotriene receptor 1 as potential prognostic biomarkers for patients with colon cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells
(
- Contribution to journal › Article
- 2018
-
Mark
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer
(
- Contribution to journal › Article
- 2017
-
Mark
M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases
(
- Contribution to journal › Article
-
Mark
A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells
(
- Contribution to journal › Article
- 2016
-
Mark
The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model
(
- Contribution to journal › Article
-
Mark
Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells
(
- Contribution to journal › Article
- 2013
-
Mark
The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells
(
- Contribution to journal › Article